Drugs / Amino Acid chelated iron
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03830034 | Feb → Oct 2019 | iron deficiency anemia | Ain Shams University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02005588 Comparator | Dec 2013 → Jun 2015 | iron deficiency anemia | Cairo University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03542825 Comparator | Jan → Sep 2018 | iron deficiency anemia | South Valley University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amino acid chelated iron | “Amino acid chelated iron capsules contain 15 mg” NCT03542825 ↗ |
| Known as | ferrotrone | “Contain 75 pregnant women will recommended to take ferrotrone(iron chelated amino acid containing 15mg elemental iron)” NCT03830034 ↗ |
| Route | Oral | “two preparations of oral iron” NCT02005588 ↗ |